Mielopatía por causa dual: neurosífilis y deficiencia de ácido fólico: reporte de caso

Kitley J, Leite M, George J, Palace J. The differential diagnosis of longitudinally extensive transverse myelitis. Multiple Sclerosis Journal. 2011;18(3):271-85.

Guerrero-Vega J, Ariza-Serrano LM, Ortiz P. Enfoque práctico de la neurosífilis meningovascular: a propósito de un caso presuntivo. Acta Neurol Colomb. 2016;32(3):233-7.

Marra CM. Neurosyphilis. En: Scheld WM, Whitley RJ, Marra CM, editores. Infections of the central nervous system, 4.a ed. Philadelphia, PA: Wolters Kluwer Health; 2014. p. 659-73.

Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab. 2000;71(1-2):121-38.

Jacob A, Weinshenker B. An approach to the diagnosis of acute transverse myelitis. Semin Neurol. 2008;28(1):105-20.

Uribe CS, Jiménez JA. El problema del diagnóstico en el trastorno del espectro neuromielitis óptica. Acta Neurol Colomb. 2016;32(3):181-3.

Ramírez CB, Urrea E, Ramírez SF. Visión borrosa y mielitis transversa como presentación de una patología desmielinizante. Enfermedad de Devic. Acta Neurol Colomb. 2005;21(2):174-7.

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology.2015;85(2):177-89.

Schwendimann RN. Metabolic and toxic myelopathies. Continuum (Minneap Minn). 2018;24(2):427-40.

Goh C, Desmond PM, Phal PM. MRI in transverse myelitis. J Magn Reson Imaging. 2014;40(6):1267-79.

Marra CM. Neurosyphilis. Continuum (Minneap Minn). 2015;21(6 Neuroinfectious Disease):1714-28. doi: 10.1212/CON.0000000000000250.

Marra CM, Castro CD, Kuller L, Dukes AC, Centurion-Lara A, Morton WR, et al. Mechanisms of clearance of Treponema pallidum from the CSF in a nonhuman primate model. Neurology.1998;51(4):957-61.

Chahine LM, Khoriaty RN, Tomford WJ, Hussain MS. The changing face of neurosyphilis. Int J Stroke. 2011;6(2):136-43.

Berger JR. Infectious myelopathies. Continuum (Minneap Minn). 2011;17(4):761-75.

Harding AS, Ghanem KG. The performance of cerebrospinal fluid treponemal-specific antibody tests in neurosyphilis: a systematic review. Sex Transm Dis. 2012;39(4):291-7.

Uribe CS, García FA. Neurosífilis y efecto prozona. Rev Neurol. 1998(27):970-2.

He D, Jiang B. Syphilitic myelitis: Magnetic resonance imaging features. Neurol India. 2014;62(1):89-91.

Shih RY, Koeller KK. Bacterial, fungal, and parasitic infections of the central nervous system: radiologic-pathologic correlation and historical perspectives: from the radiologic pathology archives. Radiographics. 2015;35(4):1141-69.

Devalia V, Hamilton MS, Molloy AM, British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4): 496-513.

Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015 [published correction appears in MMWR Recomm Rep. 2015;64(33):924]. MMWR Recomm Rep. 2015;64(RR-03):1-137.

Clement ME, Okeke NL, Hicks CB. Treatment of syphilis. Jama. 2014;312(18):1905-17.

Chilver-Stainer L, Fischer U, Hauf M, Fux CA, Sturzenegger M. Syphilitic myelitis: rare, nonspecific, but treatable. Neurology. 2009;72(7):673-5.